Finally, although we found that Mrtfab−/− MEFs apparently exhibit increased cell plasticity, a phenotype associated with therapy-induced cancer cell senescence (Milanovic et al., 2018), MRTF–SRF activity has also been previously reported to suppress plasticity in non-senescent cells (Hu et al., 2019). The gene discussed is SRF; the disease is cancer.